Top 4 SBI Mutual Fund Schemes with Over 30% Returns in the Last 5 Years

SBI Mutual Fund, India’s largest fund house by assets under management (AUM), has consistently contributed high-performing schemes to the mutual fund industry. Known for its wide range of offerings and robust investment strategies, the fund house continues to play a significant role in wealth creation for Indian investors.

As per the Association of Mutual Funds in India (AMFI), for the Q3FY25, SBI Mutual Fund reported an average AUM of ₹11,13,952 crore. This figure includes overseas funds of funds and excludes domestic funds of funds.

Schemes with Over 30% Five-Year Returns

Several schemes from the SBI Mutual Fund portfolio have stood out for their strong 5-year performance. 4 schemes have delivered annualised returns ranging from 30.36% to 34.21%, demonstrating resilience and strong asset selection across market cycles.

Mutual Fund Schemes 
SBI Contra Fund
SBI Magnum Midcap Fund
SBI Infrastructure Fund
SBI PSU Fund

Here’s a breakdown of these top-performing schemes:

SBI Contra Fund

  • Assets Under Management: ₹42,220 crore 
  • Expense Ratio: 1.51% 
  • Benchmark Index: BSE 500 TRI 
  • NAV (Regular Plan): ₹357.21 
  • 5-Year Return: 34.21% (Annualised)

Note: NAV is as of April 15 and its regular plan. 

SBI Magnum Midcap Fund

  • Assets Under Management: ₹20,890.30 crore 
  • Expense Ratio: 1.67% 
  • Benchmark Index: Nifty Midcap 150 TRI 
  • NAV (Regular Plan): ₹222 (April 16)  
  • 5-Year Return: 31.84% (Annualised)

SBI Infrastructure Fund 

  • Assets Under Management: ₹4,681 crore 
  • Expense Ratio: 1.90% 
  • Benchmark Index: Nifty Infrastructure TRI 
  • NAV (Regular Plan): ₹46.79 (April 16)  
  • 5-Year Return: 31.52% (Annualised)

SBI PSU Fund 

  • Assets Under Management: ₹4,788.80 crore 
  • Expense Ratio: 1.88% 
  • Benchmark Index: BSE PSU TRI 
  • NAV (Regular Plan): ₹30.22 (April 16)  
  • 5-Year Return: 30.36% (Annualised)

Conclusion

While past performance does not guarantee future results, these schemes from SBI Mutual Fund reflect consistent fund management and strong thematic positioning. Investors exploring different mutual fund strategies may find it useful to track such long-term performance trends across various fund categories.

Curious about your SBI SIP returns? Get accurate estimates of your investment growth using our SBI SIP Calculator and stay ahead of your financial goals.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Mutual Fund investments in the securities market are subject to market risks, read all the related documents carefully before investing.

India Considers Waiving Import Duties on US Ethane and LPG to Bolster Trade Relations

India is considering the removal of import duties on US ethane and liquefied petroleum gas (LPG) as part of its broader trade negotiations with the United States, as per Reuters news report citing sources. 

 

This decision aligns with New Delhi’s aim to reduce its trade surplus and contribute to the bilateral target of achieving $500 billion in trade by 2030. The potential move also reflects India’s interest in easing tariff burdens amid shifting global trade dynamics.

US Energy Imports May Get a Boost

At present, India levies a 2.5% import tax on ethane, propane, and butane. These fuels are crucial for petrochemical production and cooking gas. In the fiscal year 2023–24, India imported 18.5 million metric tons of LPG worth $10.4 billion, mostly from the Middle East. 

 

However, India is also the world’s second-largest buyer of U.S. ethane, following China, having imported 65,000 barrels per day last year. With China’s imports declining due to trade tensions, India could become an even more important destination for U.S. exports.

 

Reliance Industries, which runs the world’s largest petrochemicals complex, remains India’s primary ethane importer. Scrapping import duties could enhance profitability and secure more stable feedstock supplies for such firms.

Growth Potential Limited by Infrastructure

Despite these trade prospects, experts highlight that India’s current infrastructure poses challenges for a rapid increase in ethane imports. 

 

As per news reports, India’s steam cracker capacity, currently at 9.5 million metric tons of ethylene output can only process up to 2 million tons (92,000 barrels per day) of ethane. The shortage of specialised ships and storage tanks further constrains expansion.

In contrast, expanding LPG imports appears more practical. India already imports nearly 60% of its LPG demand, and industry experts suggest that sourcing a greater share from the US is logistically feasible in the short term.

Conclusion

India’s potential removal of duties on U.S. ethane and LPG signals a strategic effort to deepen trade ties while addressing its trade surplus with Washington. 

While infrastructural limitations may restrict immediate growth in ethane imports, the LPG segment offers more immediate scalability. Final decisions will depend on reviews by India’s commerce and finance ministries, according to the news report.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

HomeFirst Finance Shares in Focus on Securing ₹1,250 Crores Through QIP

Home First Finance Company India Limited (HomeFirst) has successfully secured ₹1,250 crores via a Qualified Institutions Placement (QIP), marking its first major equity fundraise since its IPO in 2021.

 

This significant development showcases the growing investor confidence in HomeFirst’s affordable housing finance model, driven by its technology-led operations and deep market reach.

Institutional Trust and Strategic Capital Deployment

HomeFirst’s latest fundraising involved the issuance of 1.3 crore equity shares to Qualified Institutional Buyers under SEBI’s ICDR regulations. 

 

The QIP attracted substantial interest from a blend of foreign and domestic institutional investors, including International Finance Corporation, Fidelity International, Goldman Sachs Asset Management, HDFC AMC, ICICI Prudential AMC, and Bajaj Allianz Life Insurance, among others.

This overwhelming response reflects the market’s belief in HomeFirst’s resilient business model and long-term vision. As highlighted by Managing Director & CEO Manoj Viswanathan, the capital will not only bolster the company’s financial base but also enable deeper customer engagement and geographic expansion. 

Investors’ faith, according to Viswanathan, is a testament to the firm’s consistent and sustainable growth record over the past fifteen years.

Technology-Driven Expansion in Affordable Housing

Operating as a technology-driven housing finance provider, HomeFirst primarily targets first-time homeowners from low and middle-income groups. The company offers housing loans for purchase and construction and operates through 155 branches across 13 Indian states and union territories. 

Its presence is especially prominent in urban and semi-urban areas of Gujarat, Maharashtra, and the southern states, while it is also expanding across Uttar Pradesh, Madhya Pradesh, and Rajasthan.

 

HomeFirst’s diversified lead-generation model and broad network of connectors have helped it maintain steady momentum in India’s evolving affordable housing finance sector. This robust network, paired with efficient service delivery through digital channels, continues to set it apart from traditional housing finance competitors.

HomeFirst Finance Share Performance 

As of April 17, 2025, at 11:30 HomeFirst Finance Share Price is trading at ₹1,165, reflecting a 0.86% decline from the previous closing price.

Conclusion

The ₹1,250 crore raised through QIP signifies more than just a financial transaction; it represents a strong endorsement of HomeFirst’s value proposition, governance, and future prospects.

As the company scales its operations further, this infusion is expected to support both strategic growth and a continued commitment to making homeownership accessible for underserved segments across India.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

 

Glenmark Pharma Share Price in Focus on Launching Generic Adderall Tablets in US

Glenmark Pharmaceuticals Inc., USA, a subsidiary of Glenmark Pharmaceuticals Ltd., has announced the upcoming launch of its generic version of the widely prescribed medication Adderall. 

 

This development is seen as a timely response to the prevailing shortage of the drug in the United States. With distribution scheduled to commence in May 2025, the launch demonstrates Glenmark’s commitment to enhancing access to essential medicines.

Product Launch to Address Critical Demand in the US

Glenmark’s new offering includes Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulphate and Amphetamine Sulphate Tablets—known collectively as Mixed Salts of a Single Entity Amphetamine Product—available in 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg strengths.

 

The formulation is bioequivalent and therapeutically equivalent to the reference listed drug Adderall®, manufactured by Teva Women’s Health, Inc. According to IQVIA™ sales data, the US market for these tablets reached approximately $421.7 million in sales in the twelve months ending February 2025. The launch is poised to support patients by enhancing the availability of a critical treatment option.

Glenmark’s Global Reach and Sustainable Vision

Commenting on the launch, Marc Kikuchi, President and Business Head, North America, highlighted “Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 10 mg, 15 mg, 20 mg and 30 mg is a highly prescribed medication in the United States.

Glenmark is very pleased to be able to help alleviate the shortage this country has been facing with this upcoming launch.” 

Glenmark Pharmaceuticals Ltd., the parent company, operates across branded, generic, and OTC product segments, focusing on key therapeutic areas such as cardiometabolic, respiratory, dermatology, and oncology. With 11 manufacturing facilities across four continents and a presence in over 80 countries, Glenmark ranks among the top 100 global biopharmaceutical firms. 

The company’s environmental initiatives, including greenhouse gas emission reduction targets validated by the Science Based Target initiative, further illustrate its holistic approach to healthcare and sustainability.

Glenmark Pharmaceuticals Share Performance 

As of April 17, 2025, at 10:30 AM Glenmark Pharmaceuticals Share Price is trading at ₹1,351.50, reflecting a 0.39% down from the previous close.

Conclusion

The anticipated launch of Glenmark’s generic version of Adderall® marks a significant advancement in the company’s North American strategy. By addressing a pressing market need and showcasing its robust manufacturing and distribution capabilities, Glenmark continues to assert its position as a key global player in the pharmaceutical industry.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

DLF Share Price Rise on Signing ₹693 Crore Deal to Sell Kolkata IT SEZ to Srijan Group

DLF Limited has signed a Master Framework Agreement (MFA) with Srijan Realty Private Limited and its subsidiaries to sell its IT/ITeS Special Economic Zone (SEZ) located in Kolkata. The deal is valued at ₹693 crore and will be executed through a slump sale. The agreement was formalised on April 16, 2025.

As of 11:04 AM on April 17, 2025, shares of DLF Ltd were trading at ₹663.10, a 1.04% up and 23.24% over the past six months.

What the Transaction Includes

The sale involves a 25.90-acre freehold land parcel and the DLF Tech Park building. The total leasable area of the property stands at 10,54,357 square feet. The transfer will take place through a Business Transfer Agreement and conveyance deeds between DLF and Srijan Group companies.

Previous Transaction in Kolkata

This is the second IT park that DLF has sold in Kolkata. In November 2024, a wholly owned DLF subsidiary agreed to sell Kolkata Tech Park 1 to RDB Primarc Techno Park LLP for ₹637 crore, also through a slump sale.

Revenue and Compliance Details

The Kolkata SEZ being sold generated ₹86.26 crore in revenue in FY24, accounting for 2.11% of DLF’s total turnover. The buyer entities, Gangapurna Projects LLP and Makalu Builders LLP are subsidiaries of Srijan Realty. 

They are not part of DLF’s promoter or group companies. The transaction is not part of any scheme of arrangement and does not qualify as a “material undertaking” under the Companies Act, 2013.

Payment and Timeline

The entire consideration will be paid in cash, subject to adjustments as per the terms of the MFA. The transaction is dependent on certain conditions precedent, including regulatory approvals, consents, and other formal clearances. The deal is expected to close within 12 months, though the timeline can be extended if required.

Conclusion

DLF continues to divest non-core commercial assets, with this being its second IT park sale in Kolkata within a year.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

CCI Approves Patanjali’s Acquisition of Magma General Insurance

The Competition Commission of India (CCI) has cleared a proposal involving Patanjali Ayurved Ltd. and five related entities to acquire a majority stake in Magma General Insurance Ltd. The approval was granted through the green channel route under Section 6(4) of the Competition Act, 2002.

As of 9:15 AM on April 17, 2025, Patanjali Foods share price was trading at ₹1994.10, a 0.33% down, with gains of 15.06% over the past six months and 42.64% over the past year.

Transaction Overview

The acquisition involves a deal valued at ₹4,500 crore. Sanoti Properties LLP, jointly held by Adar Poonawalla and Rising Sun Holdings Pvt. Ltd. – had earlier approved the sale of its insurance subsidiary, Magma General Insurance, to Patanjali and the Dharampal Satyapal Group.

Entities participating in the transaction include:

  • Patanjali Ayurved Ltd.
  • S R Foundation
  • Riti Foundation
  • RR Foundation
  • Suruchi Foundation
  • Swati Foundation

Following this acquisition, Patanjali is set to become the promoter entity of Magma General Insurance.

Green Channel Route

The deal was filed under the green channel route, which permits automatic approval for combinations that do not raise concerns related to competition. As per the CCI, the transaction does not involve any horizontal overlaps, vertical relationships, or complementary business linkages among the parties involved.

About Magma General Insurance

Magma General Insurance offers more than 70 products across both retail and commercial segments. Its offerings include:

  • Retail: Motor, health, home, and personal accident insurance
  • Commercial: Fire, engineering, marine, liability insurance

The company operates in the general insurance space, which continues to have low penetration in many parts of India.

Background and Current Status

The deal was announced last month and has now received regulatory clearance. No objections were raised by the competition authority, and the transaction is expected to proceed with the standard post-approval processes.

Conclusion

With the CCI approval now in place, the proposed acquisition of Magma General Insurance by Patanjali and associated entities will move forward under regulatory compliance.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

UltraTech Cement to Pick Up 26% Stake in Solar Power firm AMPIN C&I Power for ₹25.5 Crore

UltraTech Cement Limited has entered into an agreement to acquire 26% equity in AMPIN C&I Power Eight Private Limited. The deal is valued at up to ₹25.5 crore and will be completed through a cash transaction. The company has signed an Energy Supply Agreement as well as a Share Subscription and Shareholders Agreement.

As of 9:27 AM on April 17, 2025, UltraTech Cement share price was trading at ₹11,633, a 0.81% down, having gained 6.57% over the past six months and 25.13% over the past year.

Purpose of the Investment

The acquisition is to support UltraTech’s captive power needs using renewable energy. It is also aimed at bringing down power costs and meeting requirements under electricity laws related to captive consumption.

About the Project

AMPIN C&I Power Eight was incorporated on January 29, 2025. It is a special-purpose vehicle set up to build a solar power project with a capacity of 75 MWp DC / 50 MW AC. The project is located in Village Sindhari, Balotra district, Rajasthan. The SPV is focused on solar energy generation and transmission and currently does not have any financial history as it is a newly incorporated entity.

The registered office of the target company is in Saket, New Delhi. The upcoming solar project will function as a captive power source. No foreign presence or historical turnover is associated with the SPV.

Regulatory and Transaction Structure

The acquisition does not involve any related parties, and there is no promoter group interest in the target entity. The stake buy is expected to close within 180 days from the date of agreement execution.

Company Overview

UltraTech Cement is part of the Aditya Birla Group. It operates with a consolidated grey cement capacity of 183.06 million tonnes per annum. The company is involved in manufacturing and distribution of cement and building solutions across several markets.

Conclusion

UltraTech Cement’s acquisition of a minority stake in a solar SPV is intended to secure renewable energy for captive use. The transaction is expected to be finalised within the agreed timeframe.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

HUL Approaches Bombay High Court Over Sunscreen Ad Against Honasa Consumer

Hindustan Unilever Ltd (HUL) has moved the Bombay High Court against Honasa Consumer, alleging that one of its advertisements targets and disparages the Lakmé brand. The ad in question, released by The Derma Co (a Honasa brand), appeared on a billboard and read: “Hey Lakmé, Congratulations on finally getting SPF 50 in-vivo tested. Welcome to The Derma Co Standard.” HUL has sought a court order to stop Honasa from making further such references.

As of 9:23 AM on April 17, 2025, Hindustan Unilever share price was trading at ₹2346, a 0.87% down, while Honasa Consumer share price was trading at ₹229.57, a 0.23% down.

Parallel Case in Delhi High Court

This development follows a separate case filed earlier by Honasa Consumer in the Delhi High Court. The company alleged that a Lakmé advertisement titled SPF Lie Detector Test was misleading and portrayed competing sunscreens as delivering lower SPF protection than claimed. The visuals used in the ad reportedly resembled Derma Co’s sunscreen packaging.

Observations from the Delhi Court

At a preliminary hearing on April 16, the Delhi High Court noted that the Lakmé advertisement appeared “disparaging on the face of it.” The court stated that while comparative advertising is allowed, a trader cannot defame a competitor’s product. HUL has been asked to respond. The next hearing is scheduled for April 17.

Disagreement Over SPF Claims

The dispute centres around in-vivo SPF testing, a clinical method used to verify sun protection levels. HUL stated that Lakmé products have followed in-vivo testing standards since 2015. Honasa has also cited in-vivo results, noting its SPF 50 product was tested and certified at SPF 50.169.

Statements and Media Remarks

Honasa co-founder Ghazal Alagh shared the Derma Co billboard on social media, indirectly referring to the Lakmé campaign. She also commented on increased competition in the skincare segment.

Both cases come at a time when India’s sunscreen market is growing, estimated at around ₹2,000 crore, as per the reports. The legal dispute has brought focus on the lack of clear advertising regulations in the country.

Conclusion

With both companies now involved in parallel legal proceedings in different courts, the dispute marks a larger conversation about advertising practices and product testing in India’s personal care industry.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

ArcelorMittal Nippon Steel to Invest ₹60,000 Crore for Green Steel Expansion in India

ArcelorMittal Nippon Steel (AM/NS) India has announced a ₹60,000 crore Phase-I investment plan focused on expanding steel capacity, increasing renewable energy usage, and setting up additional scrap processing facilities.

The initiative is intended to align with the green steel taxonomy introduced by the Indian government in December 2024.

Capacity and Infrastructure Plans

AM/NS will expand production at its Hazira plant in Gujarat from 9 million tonnes per annum (MTPA) to 15 MTPA. 

It will also build three new scrap processing facilities across India, adding to its existing unit in Khopoli, Maharashtra. The company plans to increase the share of scrap-based input in production.

Government’s Green Steel Guidelines

As per the new taxonomy, steel products with less than 2.2 tonnes of CO₂ equivalent emissions per tonne of finished steel will be eligible for a star-based rating system. 

Steelmakers can qualify for a three-, four-, or five-star rating, with five being the lowest emissions category. The National Institute of Secondary Steel Technology (NISST) has been designated the nodal verification agency.

Target Output 

AM/NS India is targeting 70% of its output to qualify for a three-star rating by FY27. At present, 60-65% of the company’s steel is made through the gas-based direct reduced iron (DRI) process. The firm also plans to increase renewable energy usage through its hybrid energy project in Kurnool, Andhra Pradesh.

Scrap Supply Constraints

India’s domestic ferrous scrap production rose by 8% in FY25 to reach 32 million tonnes. However, the year also recorded a shortfall of 8.5 million tonnes. Reports suggest that Scrap demand is projected to reach 60-65 million tonnes by FY30, driven by steel demand growth. AM/NS is planning to scale up internal scrap processing to bridge part of the gap.

Conclusion

AM/NS India’s investment is structured around production growth, compliance with carbon emission norms, and securing raw material through scrap. The announcement comes shortly after JSW Steel declared its own investment plan of ₹50,000-60,000 crore for green steel production in Maharashtra.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Zepto Renames Parent Company From Kiranakart Ahead of IPO

As per news reports, Zepto has changed its parent company name from Kiranakart Technologies Private Limited to Zepto Private Limited. The approval for this change was granted by the Registrar of Companies (RoC), Mumbai. The decision comes as the company continues preparations for an upcoming Initial Public Offering (IPO).

Legal Name Change in Context

Zepto’s legal name change follows similar actions by competitors. Swiggy changed its name from Bundl Technologies to Swiggy Private Limited before filing for an IPO in February 2024. Zomato has renamed its parent company to Eternal Limited to consolidate multiple business verticals.

Company History 

Zepto was incorporated in 2021. It initially operated under the name KiranaKart, offering grocery delivery by partnering with local stores. Later that year, the company rebranded to Zepto and shifted to a dark store model. It currently operates more than 700 dark stores across urban areas and delivers over 25,000 products.

Board Composition

The company’s board includes co-founders Aadit Palicha and Kaivalya Vohra, along with Anu Hariharan (Avra), Suvir Sujan (Nexus Venture Partners), and Akhil Gupta (Bharti Enterprises).

In the past five months, Zepto has raised approximately $1.35 billion:

  • $665 million in June 2024
  • $340 million in August 2024
  • $350 million from investors including Motilal Oswal and Claypond Capital

Reports suggest that the company is currently in talks to raise an additional $300 million through a secondary round, primarily from domestic mutual fund houses.

Other Verticals

In April 2022, Zepto launched Zepto Cafe, a separate vertical focused on coffee and ready-to-eat food delivery. As of February 2025, it records 1 lakh daily orders and has reached an annualised GMV run rate of $100 million. A standalone app for Zepto Cafe was launched in December 2024.

Conclusion 

Zepto’s estimated GMV is around $4 billion. The quick commerce market in India is currently valued at over $6 billion and is projected to reach $25-30 billion in the next few years.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.